Kathleen D. LaPorte has served on our Board since November 2002.  She is a Partner of New Leaf Venture Partners, LLC. Previously, Ms. LaPorte was a General Partner of the Healthcare Technology Group of the Sprout Group, which she joined in 1993 and became a General Partner of in 1994. Between 1987 and 1993, Ms. LaPorte was a principal at Asset Management Company, a venture capital firm focused on early-stage investments. Previously, Ms. LaPorte was a financial analyst with The First Boston Corporation.  Ms. LaPorte received a B.S. from Yale University and an M.B.A. from Stanford University Graduate School of Business.
In the past five years, Ms. Laporte has served as a member of the boards of directors of VNUS Medical Technologies, Inc., eHealth, Inc. and Adeza BioMedical Corp., which later merged with Cytyc Corp., all of which are public companies, as well as Prometheus Laboratories, Inc., which is a private company.  Ms. LaPorte brings to the Board extensive experience in the areas of venture capital and fund raising.